Phase I clinical and pharmacokinetic trial of docetaxel and irinotecan administered on a weekly scheduleGARCIA, Agustin A; PUJARI, Mahesh; JEFFERS, Susan et al.Cancer chemotherapy and pharmacology. 2005, Vol 56, Num 1, pp 75-82, issn 0344-5704, 8 p.Article

Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathyVAHDAT, Linda T; GARCIA, Agustin A; VOGEL, Charles et al.Breast cancer research and treatment. 2013, Vol 140, Num 2, pp 341-351, issn 0167-6806, 11 p.Article

Phase I escalation of gemcitabine combined with protracted oral etoposide in gynecologic malignancies: A Gynecologic Oncology Group StudyGARCIA, Agustin A; BOOKMAN, Michael A; RODRIGUEZ-RODRIGUEZ, Lorna et al.Investigational new drugs. 2002, Vol 20, Num 4, pp 383-387, issn 0167-6997, 5 p.Article

Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer : A Trial of the California, Chicago, and Princess Margaret Hospital Phase II ConsortiaGARCIA, Agustin A; HIRTE, Hal; SCUDDER, Sidney et al.Journal of clinical oncology. 2008, Vol 26, Num 1, pp 76-82, issn 0732-183X, 7 p.Article

Phase II clinical trial of 5-fluorouracil, trimetrexate, and leucovorin (NFL) in patients with advanced pancreatic cancerGARCIA, Agustin A; LEICHMAN, Lawrence; BARANDA, Joaquina et al.International journal of gastrointestinal cancer. 2003, Vol 34, Num 2-3, pp 79-86, issn 1537-3649, 8 p.Article

Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumorsPIATEK, Caroline I; RAJA, Grace L; GARCIA, Agustin A et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 6, pp 1227-1234, issn 0344-5704, 8 p.Article

Clinical activity of pertuzumab (rhuMAb 2C4), a her dimerization inhibitor, in advanced ovarian cancer : Potential predictive relationship with tumor HER2 activation statusGORDON, Michael S; MATEI, Daniela; COHN, David E et al.Journal of clinical oncology. 2006, Vol 24, Num 26, pp 4324-4332, issn 0732-183X, 9 p.Article